Long-term Outcomes of PreserFlo MicroShunt versus XEN45 Gel Stent in Open-Angle Glaucoma.
Matthias NoblSigrid FreissingerKatrin RudolphEfstathios VounotrypidisStefan KassumehSiegfried PriglingerMarc Julian MackertPublished in: Klinische Monatsblatter fur Augenheilkunde (2023)
Both MicroShunt and XEN are effective in significantly reducing IOP and glaucoma medications in OAG, and with a good safety profile.